PMID: 11922404Apr 2, 2002Paper

Assessing the impact of migraine

Current Medical Research and Opinion
A J Dowson

Abstract

Migraine is a remarkably disabling condition, although unpredictable and heterogeneous in frequency, duration and severity. It can be difficult to manage in primary care, where it is under-recognised, under-diagnosed and under-treated. Proposals have been made that migraine care could be improved by incorporating assessments of migraine impact into management strategies. Research has shown that measuring headache-related disability, together with assessments of pain intensity, headache frequency, tiredness, mood alterations and cognition can be used to assess the impact of migraine on sufferers' lives and society. From this research, two simple and brief impact tools were developed: the Migraine Disability Assessment (MIDAS) Questionnaire and the Headache Impact Test (HIT). Both tools are scientifically valid measures of migraine severity and have the potential to improve communication between patients and their physicians, assess migraine severity and act as outcome measures to monitor treatment efficacy. Each of these tools offers its own advantages. For example, HIT was designed for greater accessibility (on the Internet at www.headachetest.com and www.amlhealthy.com, and as a paper-based form known as HIT-6) and has a wider...Continue Reading

References

Aug 1, 1992·Pain·Michael Von KorffSamuel F Dworkin
May 1, 1995·Cleveland Clinic Journal of Medicine·T A Lewis, G D Solomon
Sep 24, 1994·BMJ : British Medical Journal·I Abu-Arefeh, G Russell
Feb 1, 1997·Cephalalgia : an International Journal of Headache·F Sakai, H Igarashi
May 28, 1998·Cephalalgia : an International Journal of Headache·W F StewartJ Liberman
Jun 20, 1998·Neurology·M Von KorffR B Lipton
Apr 24, 1999·Cephalalgia : an International Journal of Headache·W F StewartJ Sawyer
Jan 20, 2000·Current Medical Research and Opinion·A Dowson, S Jagger
Nov 15, 2000·Cephalalgia : an International Journal of Headache·F Sakai
Nov 22, 2000·JAMA : the Journal of the American Medical Association·R B LiptonUNKNOWN Disability in Strategies of Care Study group
Apr 11, 2001·Neurology·N Breslau, B K Rasmussen
Jun 26, 2001·Cephalalgia : an International Journal of Headache·P J GoadsbyC J Boes
Jul 27, 2001·Cephalalgia : an International Journal of Headache·F AntonaciG Nappi
Oct 27, 2001·Cephalalgia : an International Journal of Headache·H C Diener
Dec 12, 2001·Cephalalgia : an International Journal of Headache·C Dahlöf

❮ Previous
Next ❯

Citations

May 7, 2008·Journal of General Internal Medicine·Richard B LiptonMeaghan R Nelson
Nov 12, 2005·Current Pain and Headache Reports·Marcelo E Bigal, Richard B Lipton
Oct 8, 2014·Brain Injury : [BI]·Nathan D Zasler
Oct 2, 2008·Journal of the American Pharmacists Association : JAPhA·Richard G Wenzel
Feb 5, 2003·Current Medical Research and Opinion·A MainA Dowson
Dec 19, 2002·Current Medical Research and Opinion·A J DowsonUNKNOWN MIPCA Migraine Guidelines Development Group. Migraine In Primary Care Advisors

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.